Spinal Cord Injury

Because the 2 active doses did not significantly differ from each other in terms of analgesic potency, the lower dose appears to offer the best risk-benefit ratio in patients with neuropathic pain associated with injury or disease of the spinal cord.

https://www.ncbi.nlm.nih.gov/pubmed?term=27286745